The purchase brings Covidien into the gastroenterology field. Barrx will be operated as a standalone division of Covidien and staffed by current Barrx employees.
The company’s offerings include the Halo system, a radiofrequency ablation device to treat Barrett’s esophagus by using radiofrequency energy to remove a thin layer of tissue off the inner esophageal lining so healthy tissue can grow.
Related Articles on Gastroenterology:
Study: Laparoscopic Surgery May be Safer Than Open Bariatric Surgery
Median Survival Time for Colon Cancer Increases 17-Fold
IBD Patients Face Higher Risk of Skin Cancer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.